Visser, Otto

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet

Global Cancer Incidence and ScreeningColorectal Cancer Screening and Detection

Cited by 6,145

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands

Dinmohamed, A. G., Visser, O., Verhoeven, R. H. A., Louwman, M. W. J., van Nederveen, F. H., Willems, S. M., Merkx, M. A. W., Lemmens, V. E. P. P., Nagtegaal, I. D., & Siesling, S. (2020) · The Lancet Oncology

COVID-19 and healthcare impactsGlobal Cancer Incidence and Screening

Cited by 699

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

Gatta, G., Capocaccia, R., Botta, L., Mallone, S., De Angelis, R., Ardanaz, E., Comber, H., Dimitrova, N., Leinonen, M. K., Siesling, S., et al. (2017) · The Lancet Oncology

Global Cancer Incidence and ScreeningAdvances in Oncology and Radiotherapy

Cited by 516

Radiation exposure from pediatric CT scans and subsequent cancer risk in The Netherlands

Meulepas, J. M., Ronckers, C. M., Smets, A. M. J. B., Nievelstein, R. A. J., Gradowska, P., Lee, C., Jahnen, A., van Straten, M., de Wit, M.-C. Y., Zonnenberg, B., et al. (2019) · JNCI Journal of the National Cancer Institute

Radiation Dose and ImagingEffects of Radiation Exposure

Cited by 360

Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies

Braamse, A. M. J., Gerrits, M. M. J. G., van Meijel, B., Visser, O., van Oppen, P., Boenink, A. D., Cuijpers, P., Huijgens, P. C., Beekman, A. T. F., & Dekker, J. (2012) · Bone Marrow Transplantation

Cancer survivorship and careHematopoietic Stem Cell Transplantation

Cited by 101

The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population‐based study in the Netherlands, 1989–2018

Maas, C. C. H. M., van Klaveren, D., Ector, G. I. C. G., Posthuma, E. F. M., Visser, O., Westerweel, P. E., Janssen, J. J. W. M., Blijlevens, N. M. A., & Dinmohamed, A. G. (2022) · British Journal of Haematology

Chronic Myeloid Leukemia TreatmentsMultiple and Secondary Primary Cancers

Cited by 31